RRML - Increased glycemic variability in type 2 diabetes patients treated with insulin - a real-life clinical practice, continuous glucose monitoring (CGM) study
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- May 2018 -
 
Can laboratory assays for meas... 13
Phenotypic and molecular ident... 10
Romanian Review of Laboratory ... 6
Association of ischemia-modifi... 6
Antibiotic susceptibility and ... 6
Fecal microbiota transplantati... 6
Sanger sequencing of MMR genes... 5
Could fibrinogen and hsCRP be ... 5
xTAG Luminex multiplex assay f... 5
Effects of miR-99a on the migr... 5

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Ahead of print DOI:10.2478/rrlm-2018-0010
XML
TXT

Research article

Increased glycemic variability in type 2 diabetes patients treated with insulin - a real-life clinical practice, continuous glucose monitoring (CGM) study

Cristian-Ioan Crăciun, Anca-Elena Crăciun, Adriana Rusu, Corina Ioana Bocşan, Nicolae Hâncu, Anca Dana Buzoianu

Correspondence should be addressed to: Anca-Elena Crăciun

Abstract

Chronic hyperglycemia is an important cause for the development of chronic complications of diabetes, but glycemic variability has emerged in recent years as an independent contributor to diabetes-related complications. Our objective was to evaluate glycemic variability in patients with T2DM treated with insulin compared with other antidiabetic drugs. In this retrospective study, we collected 24-hour continuous glucose monitoring (CGM) recording data from 95 patients with T2DM, of which 27 treated with insulin and 68 with non-insulin treatment. We calculated and compared 16 glucose variability parameters in the insulin-treated and non-insulin treated groups. Insulin treated patients had significantly higher values of parameters describing the amplitude of glucose value fluctuations (standard deviation of glucose values, percentage coefficient of variation [%CV], and mean amplitude of glycemic excursion [MAGE], p <0.05) and time-dependent glucose variability (percentage of time with glycemic values below 70 mg/dl and continuous overall net glycemic action [CONGA] at 2, 4 and 6 hours, p <0.05). In conclusion, insulin therapy in T2DM is correlated with significantly higher glycemic variability.

Keywords: glycemic variability, insulin therapy, type 2 diabetes, continuous glucose monitoring

Received: 28.12.2017
Accepted: 15.2.2018
Published: 10.3.2018

 
  PDF Download full text PDF
(495 KB)